Analysts Are Bullish on These Healthcare Stocks: Genfit SA (GNFT), Biolinerx (BLRX)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Genfit SA (GNFT) and Biolinerx (BLRX) with bullish sentiments.

Genfit SA (GNFT)

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Genfit SA, with a price target of $72. The company’s shares opened today at $22.90.

According to TipRanks.com, Arce is a 4-star analyst with an average return of 9.5% and a 37.5% success rate. Arce covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals Inc, Arcturus Therapeutics Ltd, and Melinta Therapeutics Inc.

Genfit SA has an analyst consensus of Strong Buy, with a price target consensus of $59.25.

See today’s analyst top recommended stocks >>

Biolinerx (BLRX)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Biolinerx today and set a price target of $3. The company’s shares opened today at $0.37, close to its 52-week low of $0.35.

Pantginis noted:

“Valuation and risks to price target achievement. We reiterate our Buy rating and $3 price target. Our valuation is based on our clinical net present value (NPV) model, which is currently driven by the company’s lead asset, BL-8040. This model allows us to flex multiple assumptions affecting a drug’s potential commercial profile. Factors which could impede reaching our price target include failed or inconclusive clinical trials or inability of the company to secure adequate funding to progress its drugs through the development pathway.”

According to TipRanks.com, Pantginis is a 1-star analyst with an average return of -1.8% and a 33.7% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Iovance Biotherapeutics Inc, and Checkpoint Therapeutics Inc.

Biolinerx has an analyst consensus of Strong Buy, with a price target consensus of $2.67.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts